Merck to Use Numerate's In Silico Drug Design Platform
March 16, 2012
Merck to Use Numerate's In Silico Drug Design Platform
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Merck Invests $6M in Remedy Informatics to Support Healthcare IT Development
November 16, 2012 / BioInform - Numerate Adds Google to List of Cloud Providers for its Drug Design Platform
June 29, 2012 / BioInform - Boehringer Ingelheim Taps Numerate's Computational Platform for Infectious Disease Drug Design
December 9, 2011 / BioInform - Merck Sees Promise for Mass Spec-Based Protein Biomarker Pipeline in Drug Development
October 8, 2010 / ProteoMonitor - Slowly Maturing, Semantic Web Technologies Reach Pilot Project Stage in Pharma
March 5, 2010 / BioInform